This is a Validated Antibody Database (VAD) review about human CCR7, based on 160 published articles (read how Labome selects the articles), using CCR7 antibody in all methods. It is aimed to help Labome visitors find the most suited CCR7 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CCR7 synonym: BLR2; CC-CKR-7; CCR-7; CD197; CDw197; CMKBR7; EBI1

BioLegend
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 2s5a
BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on human samples (fig 2s5a). elife (2020) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; 3:50; loading ...; fig 1c
BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on human samples at 3:50 (fig 1c). Science (2020) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; 1:100; loading ...; fig s20c
BioLegend CCR7 antibody (Biolegend, 353204) was used in flow cytometry on human samples at 1:100 (fig s20c). Nat Commun (2020) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 1d
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig 1d). J Immunol (2019) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig 1a). Clin Exp Immunol (2019) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; 1:50; loading ...; fig 3f
BioLegend CCR7 antibody (Biolegend, 353220) was used in flow cytometry on human samples at 1:50 (fig 3f). elife (2019) ncbi
mouse monoclonal (G043H7)
  • other; human; loading ...; fig 4a
BioLegend CCR7 antibody (BioLegend, 353247) was used in other on human samples (fig 4a). Cell (2019) ncbi
mouse monoclonal (G043H7)
  • mass cytometry; human; loading ...; fig 2b
BioLegend CCR7 antibody (Biolegend, 353202) was used in mass cytometry on human samples (fig 2b). Cell (2019) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; 1:33; loading ...; fig 6c
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples at 1:33 (fig 6c). Gastroenterology (2019) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 1f
BioLegend CCR7 antibody (BioLegend, 353226) was used in flow cytometry on human samples (fig 1f). Cell (2019) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 9a
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig 9a). J Exp Med (2019) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig s2b
BioLegend CCR7 antibody (Biolegend, 353204) was used in flow cytometry on human samples (fig s2b). Cell (2019) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CCR7 antibody (BioLegend, 353212) was used in flow cytometry on human samples (fig 2a). Cell Rep (2018) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig s5a
BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on human samples (fig s5a). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig s2d
BioLegend CCR7 antibody (BioLegend, 353226) was used in flow cytometry on human samples (fig s2d). Nat Immunol (2018) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig s1d
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig s1d). J Clin Invest (2018) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 5a
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig 5a). Mol Ther Nucleic Acids (2018) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 5a
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig 5a). J Exp Med (2018) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; fig s2e
BioLegend CCR7 antibody (BioLegend, 353233) was used in flow cytometry on human samples (fig s2e). Cell (2018) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 1d
BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on human samples (fig 1d). J Immunol (2018) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig 3a). J Virol (2018) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 4b
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig 4b). J Clin Invest (2017) ncbi
mouse monoclonal (G043H7)
  • mass cytometry; human; loading ...; fig 2a
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, BioLegend CCR7 antibody (BioLegend, G043H7) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; African green monkey; loading ...; fig s4
In order to optimize the dosing regimen of neutralizing anti-HIV-1 antibodies, BioLegend CCR7 antibody (biolegend, G043H7) was used in flow cytometry on African green monkey samples (fig s4). Nature (2017) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; 1:50; loading ...; fig s1d
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples at 1:50 (fig s1d). Nat Commun (2017) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; 1:100; loading ...; fig s2
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples at 1:100 (fig s2). JCI Insight (2017) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; rhesus macaque; loading ...; fig s8a
In order to examine the kinetics of SIV-specific CD8+ T cell cytolytic factor expression in peripheral blood, lymph node, spleen, and gut mucosa from early acute infection through chronic infection, BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on rhesus macaque samples (fig s8a). PLoS Pathog (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig s1a
In order to describe complete autosomal recessive IL-17RA deficiency in patients with chronic mucocutaneous candidiasis, BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig s1a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...
In order to characterize gammadelta T cell subsets from healthy humans, BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 2a
In order to study the contribution of T follicular helper cells to islet autoimmunity, BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig s8
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig s8). Science (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; fig 1h
In order to characterize side population T cells, BioLegend CCR7 antibody (BioLegend, G043 H7) was used in flow cytometry on human samples (fig 1h). J Clin Invest (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 2c
In order to suggest that the BRD4-p300 signaling cascade promotes antitumor T cell grafts that could be used adoptive immunotherapy, BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig 2c). J Clin Invest (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 2a
In order to study the cytolytic effector capacity of HIV-specific CD8+ T cells, BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on human samples (fig 2a). PLoS Pathog (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; rhesus macaque; loading ...
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, BioLegend CCR7 antibody (BioLegend, 353208) was used in flow cytometry on rhesus macaque samples . Nat Med (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; tbl 1
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (tbl 1). J Immunol (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; fig 1
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig 1). Int Immunol (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig s4
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend CCR7 antibody (biolegend, G043H7) was used in flow cytometry on human samples (fig s4). J Immunol (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; fig 3a
In order to analyze HIV progression traits of a selective loss of early differentiated and highly functional PD1high CD4 T cells, BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig 3a). PLoS ONE (2015) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 3a
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on human samples (fig 3a). J Immunol (2015) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 4c
In order to discuss the importance of IL-5 positive Th2 cells to allergies, BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig 4c). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; fig 4
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig 4). J Hematol Oncol (2015) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; fig 1
BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on human samples (fig 1). J Neuroimmunol (2015) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; fig 1
BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on human samples (fig 1). J Infect Dis (2015) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 2c
In order to discuss the therapeutic use of ex vivo-generated Akt-inhibited minor histocompatibility antigen-specific CD8+ T cells, BioLegend CCR7 antibody (BioLegend, G04H7) was used in flow cytometry on human samples (fig 2c). Blood (2014) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human
BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human
BioLegend CCR7 antibody (Biolegend, G043H7) was used in flow cytometry on human samples . J Virol (2015) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; tbl 1
BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (tbl 1). J Gen Virol (2015) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; fig s1
In order to investigate the impact of CCR6(+)CXCR3(+)CCR4(-) cells in latent tuberculosis infection, BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig s1). J Immunol (2014) ncbi
mouse monoclonal (G043H7)
  • flow cytometry; human; loading ...; fig 2b
In order to assess how different concentrations of IFN-gamma affect dendritic cells, BioLegend CCR7 antibody (BioLegend, G043H7) was used in flow cytometry on human samples (fig 2b). J Leukoc Biol (2014) ncbi
Invitrogen
rat monoclonal (3D12)
  • flow cytometry; mouse; 1:500; loading ...; fig 4f, 5e, 5g
Invitrogen CCR7 antibody (Thermo Fisher Scientific, 47-1979-42) was used in flow cytometry on mouse samples at 1:500 (fig 4f, 5e, 5g). elife (2020) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; loading ...; fig 2b
Invitrogen CCR7 antibody (eBioscience, 3D12) was used in flow cytometry on human samples (fig 2b). Front Immunol (2019) ncbi
rat monoclonal (3D12)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 3c, 3d
Invitrogen CCR7 antibody (eBioscience, 14-1979) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 3c, 3d). J Histochem Cytochem (2019) ncbi
rat monoclonal (4B12)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen CCR7 antibody (eBioscience, 4B12) was used in flow cytometry on mouse samples (fig 1a). Front Immunol (2018) ncbi
rat monoclonal (4B12)
  • flow cytometry; mouse; 1:200; loading ...; fig s5a
Invitrogen CCR7 antibody (Affymetrix/eBioscience, 4B12) was used in flow cytometry on mouse samples at 1:200 (fig s5a). J Clin Invest (2018) ncbi
rat monoclonal (4B12)
  • flow cytometry; mouse; loading ...; fig 3d
Invitrogen CCR7 antibody (eBiosciences, 4B12) was used in flow cytometry on mouse samples (fig 3d). J Cell Biol (2017) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; loading ...; fig 3a
In order to study the expression of CCR10 and CXCR3 in circulating CD8 T cells specific for human herpes simplex virus, Invitrogen CCR7 antibody (eBioscience, 3D12) was used in flow cytometry on human samples (fig 3a). J Virol (2017) ncbi
rat monoclonal (4B12)
  • flow cytometry; mouse; fig 1d
Invitrogen CCR7 antibody (eBioscience, 4B12) was used in flow cytometry on mouse samples (fig 1d). J Immunol (2017) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; loading ...; fig 3b
Invitrogen CCR7 antibody (eBiosciences, 3D12) was used in flow cytometry on human samples (fig 3b). J Immunol (2017) ncbi
rat monoclonal (4B12)
  • flow cytometry; mouse; loading ...; fig 1b
In order to report that differentiation and self-renewal arise as opposing outcomes of sibling CD4 positive T cells during challenge with influenza, Invitrogen CCR7 antibody (eBioscience, 4B12) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2017) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; loading ...; fig s7
Invitrogen CCR7 antibody (eBiosciences, 3D12) was used in flow cytometry on human samples (fig s7). PLoS Pathog (2016) ncbi
rat monoclonal (4B12)
  • flow cytometry; mouse; fig 1b
Invitrogen CCR7 antibody (eBiosciences, 4B12) was used in flow cytometry on mouse samples (fig 1b). Sci Rep (2016) ncbi
rat monoclonal (4B12)
  • flow cytometry; mouse; loading ...; fig 6c
In order to study the contribution of T follicular helper cells to islet autoimmunity, Invitrogen CCR7 antibody (eBiosciences, 4B12) was used in flow cytometry on mouse samples (fig 6c). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (4B12)
  • flow cytometry; mouse; 1:100; loading ...; fig 5b
In order to find genes that alter invariant natural killer T cell development, migration, or function, Invitrogen CCR7 antibody (eBiosciences, 4B12) was used in flow cytometry on mouse samples at 1:100 (fig 5b). Nat Commun (2016) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; loading ...; fig 4b
In order to study the cytolytic effector capacity of HIV-specific CD8+ T cells, Invitrogen CCR7 antibody (eBioscience, 3D12) was used in flow cytometry on human samples (fig 4b). PLoS Pathog (2016) ncbi
rat monoclonal (4B12)
  • blocking or activating experiments; mouse; fig 6b
Invitrogen CCR7 antibody (eBiosciences, 4B12) was used in blocking or activating experiments on mouse samples (fig 6b). Diabetes (2016) ncbi
rat monoclonal (4B12)
  • flow cytometry; mouse; loading ...; fig s2a
In order to ask if T-bet regulates other T regulatory cell functions after entering the inflammatory site, Invitrogen CCR7 antibody (eBioscience, 4B12) was used in flow cytometry on mouse samples (fig s2a). J Immunol (2016) ncbi
rat monoclonal (3D12)
  • flow cytometry; African green monkey; fig 1
In order to study lymph node-resident simian immunodeficiency virus env-specific T follicular helper cells due to vaccine induction in Rhesus Macaques, Invitrogen CCR7 antibody (eBioscience, 3D12) was used in flow cytometry on African green monkey samples (fig 1). J Immunol (2016) ncbi
rat monoclonal (4B12)
  • western blot; human; loading ...; fig 3a
In order to study the polysialylation of CCR7, Invitrogen CCR7 antibody (eBioscience, 4B12) was used in western blot on human samples (fig 3a). Science (2016) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; fig 2.b,c
In order to evaluate the immune efficacy of a single-dose inactivated hepatitis A vaccination, Invitrogen CCR7 antibody (eBioscience, 3D12) was used in flow cytometry on human samples (fig 2.b,c). Vaccine (2015) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; fig 2
In order to examine the role of lymphocyte activation gene-3 during HIV infection, Invitrogen CCR7 antibody (eBioscience, 3D12) was used in flow cytometry on human samples (fig 2). J Immunol (2015) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; fig 4
In order to describe the phenotype and functional potential of metastatic differentiated thyroid cancer-associated PD-1 positive T cells, Invitrogen CCR7 antibody (eBioscience, 3D12) was used in flow cytometry on human samples (fig 4). Cancer Immunol Res (2015) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; loading ...; fig 6
In order to study transmigration of melanoma cells in an in vitro model of blood brain barrier., Invitrogen CCR7 antibody (eBioscience, 11-1979-71) was used in flow cytometry on human samples (fig 6). Biomed Res Int (2015) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; loading ...
In order to ascertain the impact of cell-intrinsic immunity on the latent reservoir of HIV, Invitrogen CCR7 antibody (eBioscience, 3D12) was used in flow cytometry on human samples . AIDS (2015) ncbi
rat monoclonal (3D12)
  • flow cytometry; human
Invitrogen CCR7 antibody (eBioscience, 3D12) was used in flow cytometry on human samples . J Allergy Clin Immunol (2015) ncbi
rat monoclonal (3D12)
  • flow cytometry; human
In order to developed a strategy to expand umbilical cord blood T cells and test their effects after transplantation, Invitrogen CCR7 antibody (eBioscience, 3D12) was used in flow cytometry on human samples . Leukemia (2015) ncbi
rat monoclonal (3D12)
  • flow cytometry; African green monkey; fig 2
Invitrogen CCR7 antibody (ebioscience, 3D12) was used in flow cytometry on African green monkey samples (fig 2). PLoS Pathog (2014) ncbi
rat monoclonal (3D12)
  • flow cytometry; human
Invitrogen CCR7 antibody (eBioscience, 3D12) was used in flow cytometry on human samples . Mol Immunol (2014) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; fig 3
Invitrogen CCR7 antibody (eBioscience, 3D12) was used in flow cytometry on human samples (fig 3). PLoS Pathog (2014) ncbi
rat monoclonal (3D12)
  • flow cytometry; African green monkey; 1:50; fig s6
In order to decipher how susequent acute infection is supressed in T cell responses after exposure to subinfectious hepatitis C virus, Invitrogen CCR7 antibody (eBioscience, 3D12) was used in flow cytometry on African green monkey samples at 1:50 (fig s6). Nat Med (2013) ncbi
rat monoclonal (3D12)
  • flow cytometry; rhesus macaque
Invitrogen CCR7 antibody (eBioscience, 3D12) was used in flow cytometry on rhesus macaque samples . PLoS Pathog (2013) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; fig 2
In order to investigate IL-15-driven NK receptor induction in CD8+ T cells, Invitrogen CCR7 antibody (eBioscience, 3D12) was used in flow cytometry on human samples (fig 2). Immunobiology (2011) ncbi
R&D Systems
mouse monoclonal (150503)
  • flow cytometry; human; loading ...; fig 1a
R&D Systems CCR7 antibody (R&D, 150503) was used in flow cytometry on human samples (fig 1a). Arthritis Res Ther (2018) ncbi
mouse monoclonal (150503)
  • flow cytometry; human; loading ...; fig 2d
R&D Systems CCR7 antibody (R&D, 150503) was used in flow cytometry on human samples (fig 2d). Ann Rheum Dis (2018) ncbi
mouse monoclonal (150503)
  • flow cytometry; human; 1:100; loading ...; tbl s2
In order to identify and characterize follicular cytotoxic T cells, R&D Systems CCR7 antibody (R&D system, 150503) was used in flow cytometry on human samples at 1:100 (tbl s2). Nat Immunol (2016) ncbi
mouse monoclonal (150503)
  • flow cytometry; human; loading ...; fig 1
In order to discuss the importance of assessing immune competence in cancer patients, R&D Systems CCR7 antibody (R&D Systems, 150503) was used in flow cytometry on human samples (fig 1). Cancer Immunol Immunother (2014) ncbi
Abcam
domestic rabbit monoclonal (Y59)
  • immunohistochemistry - paraffin section; human; fig 6a
Abcam CCR7 antibody (Abcam, 32527) was used in immunohistochemistry - paraffin section on human samples (fig 6a). Sci Rep (2018) ncbi
domestic rabbit monoclonal (Y59)
  • western blot; human; loading ...; fig 6a
Abcam CCR7 antibody (Abcam, Y59) was used in western blot on human samples (fig 6a). Clin Transl Immunology (2016) ncbi
domestic rabbit monoclonal (Y59)
  • immunocytochemistry; rat; 1:250; fig 1
In order to examine macrophage subtypes in a rat model of contusive spinal cord injury, Abcam CCR7 antibody (Abcam, ab32527) was used in immunocytochemistry on rat samples at 1:250 (fig 1). J Neurosci Res (2015) ncbi
domestic rabbit monoclonal (Y59)
  • immunohistochemistry - paraffin section; human; 1:200
Abcam CCR7 antibody (Abcam, ab32527) was used in immunohistochemistry - paraffin section on human samples at 1:200. Oncol Lett (2013) ncbi
domestic rabbit monoclonal (Y59)
  • immunohistochemistry - paraffin section; rat; 1:1000
In order to study the osteogenic properties of bone marrow stromal cell-loaded biomimetic constructs and assess the cellular components elicited, Abcam CCR7 antibody (Abcam, ab32527) was used in immunohistochemistry - paraffin section on rat samples at 1:1000. J Tissue Eng Regen Med (2014) ncbi
Novus Biologicals
domestic goat polyclonal
  • immunohistochemistry - frozen section; mouse; loading ...; fig 5b
In order to show that although targeted inhibition of either BRAF or VEGF initially suppresses the growth of BRAF-mutant tumors, combined inhibition of both pathways results in apoptosis and long-lasting tumor responses, Novus Biologicals CCR7 antibody (Novusbio, NB100-712) was used in immunohistochemistry - frozen section on mouse samples (fig 5b). EMBO Mol Med (2017) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D3A1)
  • western blot; mouse; 1:1000; loading ...; fig s13e
Cell Signaling Technology CCR7 antibody (Cell Signaling, 11888) was used in western blot on mouse samples at 1:1000 (fig s13e). Mol Psychiatry (2018) ncbi
domestic rabbit monoclonal (D3A1)
  • western blot; human; loading ...; fig 2k
Cell Signaling Technology CCR7 antibody (Cell Signaling, 11888) was used in western blot on human samples (fig 2k). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D3A1)
  • western blot; human; 1:1000; fig 3a
Cell Signaling Technology CCR7 antibody (ell Signaling Technology, 11888) was used in western blot on human samples at 1:1000 (fig 3a). Mol Med Rep (2016) ncbi
domestic rabbit monoclonal (D3A1)
  • western blot; human; fig 6
Cell Signaling Technology CCR7 antibody (Cell Signalling, 11888) was used in western blot on human samples (fig 6). Int J Mol Med (2015) ncbi
BD Biosciences
mouse monoclonal (150503)
  • flow cytometry; human; 1:20; loading ...; fig 2b
BD Biosciences CCR7 antibody (BD Bioscience, 562381) was used in flow cytometry on human samples at 1:20 (fig 2b). elife (2020) ncbi
mouse monoclonal (150503)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CCR7 antibody (BD Biosciences, 150503) was used in flow cytometry on human samples (fig 1b). Eur J Immunol (2019) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; loading ...; fig s1a
BD Biosciences CCR7 antibody (BD Biosciences, 552176) was used in flow cytometry on human samples (fig s1a). J Clin Invest (2019) ncbi
mouse monoclonal (150503)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences CCR7 antibody (BD Biosciences, 150503) was used in flow cytometry on human samples (fig 1c). Proc Natl Acad Sci U S A (2019) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; loading ...; fig 4a
BD Biosciences CCR7 antibody (BD, 3D12) was used in flow cytometry on human samples (fig 4a). J Virol (2019) ncbi
rat monoclonal (3D12)
  • flow cytometry; rhesus macaque; loading ...; fig 1f
BD Biosciences CCR7 antibody (BD Biosciences, 3D12) was used in flow cytometry on rhesus macaque samples (fig 1f). J Virol (2019) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; loading ...; tbl 1
BD Biosciences CCR7 antibody (BD Biosciences, 557648) was used in flow cytometry on human samples (tbl 1). J Clin Invest (2018) ncbi
mouse monoclonal (150503)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences CCR7 antibody (BD, 150513) was used in flow cytometry on human samples (fig 5a). Cancer Res (2018) ncbi
mouse monoclonal (150503)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CCR7 antibody (BD Bioscience, 150503) was used in flow cytometry on human samples (fig 1a). Biol Blood Marrow Transplant (2018) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; loading ...; fig 1e
In order to study the involvement of interleukin-8 on T lymphocytes growth and function, BD Biosciences CCR7 antibody (BD Pharmingen, 3D12) was used in flow cytometry on human samples (fig 1e). Int Immunopharmacol (2017) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; loading ...; fig s1b
BD Biosciences CCR7 antibody (BD Biosciences, 3D12) was used in flow cytometry on human samples (fig s1b). PLoS ONE (2017) ncbi
mouse monoclonal (150503)
  • flow cytometry; human; loading ...; fig st12
In order to identify new types of human blood dendritic cells, monocytes, and progenitors through single-cell RNA-seq, BD Biosciences CCR7 antibody (BD, 1050503) was used in flow cytometry on human samples (fig st12). Science (2017) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; fig 1
BD Biosciences CCR7 antibody (BD Biosciences, 552176) was used in flow cytometry on human samples (fig 1). J Cell Physiol (2017) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; loading ...; fig s1b
BD Biosciences CCR7 antibody (BD Biosciences, 3D12) was used in flow cytometry on human samples (fig s1b). Immun Ageing (2017) ncbi
mouse monoclonal (150503)
  • flow cytometry; human; loading ...; fig 3e
BD Biosciences CCR7 antibody (BD Biosciences, 561271) was used in flow cytometry on human samples (fig 3e). Oncoimmunology (2016) ncbi
mouse monoclonal (150503)
  • flow cytometry; human; loading ...; fig 5b
In order to examine the potential of IL-2 to enhance T regulatory cell therapy, BD Biosciences CCR7 antibody (BD Biosciences, 150503) was used in flow cytometry on human samples (fig 5b). Clin Exp Immunol (2017) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BD Biosciences CCR7 antibody (BD Bioscience, 3D12) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, BD Biosciences CCR7 antibody (BD Pharmingen, 3D12) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; loading ...; fig 1
In order to develop a functional assay to assess the risk of developing acute graft-versus-host disease, BD Biosciences CCR7 antibody (BD Biosciences, 3D12) was used in flow cytometry on human samples (fig 1). J Immunol Res (2016) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; loading ...; fig s1c
In order to suggest that persistent immune activation causes impairment of lymphocytes to respond to chemotactic stimuli, preventing their trafficking from the blood stream to peripheral organs, BD Biosciences CCR7 antibody (BD Pharmingen, 3D12) was used in flow cytometry on human samples (fig s1c). J Immunol (2017) ncbi
mouse monoclonal (150503)
  • flow cytometry; human; loading ...; fig 3g
In order to functionally characterize herpes simplex virus-specific CD8 positive T cells, BD Biosciences CCR7 antibody (BD Pharmingen, 150503) was used in flow cytometry on human samples (fig 3g). J Virol (2017) ncbi
mouse monoclonal (150503)
  • flow cytometry; human; loading ...; tbl 3
BD Biosciences CCR7 antibody (BD Pharmingen, 150503) was used in flow cytometry on human samples (tbl 3). Brain Behav (2016) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; fig 2b
  • flow cytometry; rhesus macaque; fig 7b
In order to identify and characterize CXCR5hiCD44hiCD8 T cells in HIV-infected individuals, BD Biosciences CCR7 antibody (BD, 557648) was used in flow cytometry on human samples (fig 2b) and in flow cytometry on rhesus macaque samples (fig 7b). PLoS Pathog (2016) ncbi
mouse monoclonal (150503)
  • flow cytometry; human; loading ...; fig s3b
In order to define the contribution of CD103+ tumor-infiltrating lymphocytes to high-grade serous epithelial ovarian cancer, BD Biosciences CCR7 antibody (BD Biosciences, 150503) was used in flow cytometry on human samples (fig s3b). Oncotarget (2016) ncbi
rat monoclonal (3D12)
  • flow cytometry; rhesus macaque; loading ...; fig 4b
BD Biosciences CCR7 antibody (BD Biosciences, 3D12) was used in flow cytometry on rhesus macaque samples (fig 4b). J Virol (2016) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; loading ...; fig e2d
In order to report that patients with PTEN mutations experience autoimmunity and lymphoid hyperplasia, BD Biosciences CCR7 antibody (BD, 3D12) was used in flow cytometry on human samples (fig e2d). J Allergy Clin Immunol (2017) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; tbl 1
BD Biosciences CCR7 antibody (BD Pharmigen, 557648) was used in flow cytometry on human samples (tbl 1). Oncoimmunology (2016) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; fig 3
In order to test if CD4 positive T cells expressing immune checkpoint molecules are enriched in HIV-infected cells in patients receiving antiretroviral therapy, BD Biosciences CCR7 antibody (BD, 557648) was used in flow cytometry on human samples (fig 3). PLoS Pathog (2016) ncbi
mouse monoclonal (150503)
  • flow cytometry; human; fig 8
In order to study the promotion of the development of self-reactive T cells by hydrophobic CDR3 residues, BD Biosciences CCR7 antibody (BD Biosciences, 562555) was used in flow cytometry on human samples (fig 8). Nat Immunol (2016) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; loading ...; fig 2
In order to report the effects of PD-L1 modulation of T cell function in graft-versus-host disease, BD Biosciences CCR7 antibody (BD Bioscience, 3D12) was used in flow cytometry on human samples (fig 2). J Clin Invest (2016) ncbi
rat monoclonal (3D12)
  • flow cytometry; mouse; loading ...; fig st1
BD Biosciences CCR7 antibody (BD Pharmingen, 3D12) was used in flow cytometry on mouse samples (fig st1). J Clin Invest (2016) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; fig 3d
In order to generate a T-cell receptor-like monoclonal antibody (8F4) that binds the PR1/HLA-A2 complex and test it in preclinical models of acute myeloid leukemia, BD Biosciences CCR7 antibody (BD Biosciences, 3D12) was used in flow cytometry on human samples (fig 3d). Cytotherapy (2016) ncbi
mouse monoclonal (150503)
  • flow cytometry; human; fig 1
BD Biosciences CCR7 antibody (BD Biosciences, 150503) was used in flow cytometry on human samples (fig 1). Sci Rep (2016) ncbi
rat monoclonal (3D12)
  • flow cytometry; African green monkey; loading ...; fig s1
In order to discuss the use of flow cytometry to examine common marmosets, BD Biosciences CCR7 antibody (BD, 3D12) was used in flow cytometry on African green monkey samples (fig s1). J Med Primatol (2016) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; fig s10
In order to find predictive markers for patients that will develop gastrointestinal graft-versus-host-disease, BD Biosciences CCR7 antibody (BD Biosciences, 3D12) was used in flow cytometry on human samples (fig s10). JCI Insight (2016) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; loading ...
In order to test if the two hematopoietic systems in patients with mixed chimerism remain functional and study immunological differences, BD Biosciences CCR7 antibody (BD Biosciences, 3D12) was used in flow cytometry on human samples . PLoS ONE (2016) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; fig s1
BD Biosciences CCR7 antibody (BD Pharmingen, 3D12) was used in flow cytometry on human samples (fig s1). Cell Rep (2016) ncbi
mouse monoclonal (150503)
  • flow cytometry; human; loading ...; fig 5
BD Biosciences CCR7 antibody (BD Biosciences, 150503) was used in flow cytometry on human samples (fig 5). PLoS ONE (2016) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CCR7 antibody (BD, 552176) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; loading ...; fig 2
BD Biosciences CCR7 antibody (BD Biosciences, 3D12) was used in flow cytometry on human samples (fig 2). J Leukoc Biol (2016) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; loading ...; fig 7c
BD Biosciences CCR7 antibody (BD Bioscience, 3D12) was used in flow cytometry on human samples (fig 7c). PLoS ONE (2016) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; loading ...; fig 1d
BD Biosciences CCR7 antibody (BD, 3D12) was used in flow cytometry on human samples (fig 1d). PLoS Pathog (2016) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences CCR7 antibody (BD Pharmingen, 3D12) was used in flow cytometry on human samples (fig 5a). PLoS ONE (2016) ncbi
mouse monoclonal (150503)
  • flow cytometry; human; fig 3a
In order to analyze HIV progression traits of a selective loss of early differentiated and highly functional PD1high CD4 T cells, BD Biosciences CCR7 antibody (BD Biosciences, 150503) was used in flow cytometry on human samples (fig 3a). PLoS ONE (2015) ncbi
rat monoclonal (3D12)
  • flow cytometry; rhesus macaque; loading ...; fig s3
In order to study the CD8+ non-cytolytic antiviral response in SIV infected rhesus macaques, BD Biosciences CCR7 antibody (BD Biosciences, 3D12) was used in flow cytometry on rhesus macaque samples (fig s3). PLoS ONE (2015) ncbi
mouse monoclonal (150503)
  • flow cytometry; human; loading ...; fig s3
BD Biosciences CCR7 antibody (BD Biosciences, 150503) was used in flow cytometry on human samples (fig s3). Sci Transl Med (2015) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; 1:20
BD Biosciences CCR7 antibody (BD Biosciences, 557648) was used in flow cytometry on human samples at 1:20. Nat Commun (2015) ncbi
rat monoclonal (3D12)
  • flow cytometry; human
In order to report that alefacept depletes both memory T cells and NK cells, BD Biosciences CCR7 antibody (Becton Dickinson, 3D12) was used in flow cytometry on human samples . Biol Blood Marrow Transplant (2015) ncbi
rat monoclonal (3D12)
  • flow cytometry; rhesus macaque; fig 4
In order to elucidate how CD8 positive T cells suppress virus replication during simian immunodeficiency virus infection, BD Biosciences CCR7 antibody (BD Biosciences, 3D12) was used in flow cytometry on rhesus macaque samples (fig 4). J Virol (2015) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; loading ...; fig 2a
In order to elucidate Th17 cell polarization, depletion, and restoration in response to HIV infection and antiretroviral therapy, BD Biosciences CCR7 antibody (BD Pharmingen, 3D12) was used in flow cytometry on human samples (fig 2a). Retrovirology (2015) ncbi
mouse monoclonal (150503)
  • flow cytometry; human; 1:7700; fig 1
In order to study the immune responses of HIV-infected volunteers vaccinated against tuberculosis, BD Biosciences CCR7 antibody (BD, 560765) was used in flow cytometry on human samples at 1:7700 (fig 1). Clin Vaccine Immunol (2015) ncbi
mouse monoclonal (150503)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CCR7 antibody (BD Pharmingen, 150503) was used in flow cytometry on human samples (fig 1b). J Immunol Res (2015) ncbi
mouse monoclonal (150503)
  • flow cytometry; human
BD Biosciences CCR7 antibody (BD Biosciences, 150503) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; fig 3
BD Biosciences CCR7 antibody (BD Biosciences, 3D12) was used in flow cytometry on human samples (fig 3). PLoS ONE (2015) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; tbl s4
In order to examine the early impact of viral replicative capacity on HIV-1 immunopathogenesis, BD Biosciences CCR7 antibody (BD Biosciences, 3D12) was used in flow cytometry on human samples (tbl s4). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (150503)
  • flow cytometry; human; fig 3
BD Biosciences CCR7 antibody (BD Pharmingen, 150503) was used in flow cytometry on human samples (fig 3). J Immunol (2015) ncbi
rat monoclonal (3D12)
  • flow cytometry; pigs
In order to summarize the current knowledge on porcine alphabeta T cells, BD Biosciences CCR7 antibody (BD Biosciences, 3D12) was used in flow cytometry on pigs samples . Mol Immunol (2015) ncbi
mouse monoclonal (150503)
  • flow cytometry; human
BD Biosciences CCR7 antibody (BD, 150503) was used in flow cytometry on human samples . Nat Commun (2014) ncbi
rat monoclonal (3D12)
  • flow cytometry; human
BD Biosciences CCR7 antibody (BD Biosciences, 3D12) was used in flow cytometry on human samples . Cytotherapy (2015) ncbi
rat monoclonal (3D12)
  • flow cytometry; human
BD Biosciences CCR7 antibody (BD Biosciences, 3D12) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (150503)
  • flow cytometry; human
BD Biosciences CCR7 antibody (BD Biosciences, 150503) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (150503)
  • flow cytometry; human
BD Biosciences CCR7 antibody (BD Bioscience, 150503) was used in flow cytometry on human samples . Immunology (2015) ncbi
rat monoclonal (3D12)
  • flow cytometry; human
BD Biosciences CCR7 antibody (BD Bioscience, 3D12) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
rat monoclonal (3D12)
  • flow cytometry; human; fig 5
BD Biosciences CCR7 antibody (Pharmingen, 3D12) was used in flow cytometry on human samples (fig 5). Immunology (2015) ncbi
mouse monoclonal (150503)
  • flow cytometry; human
BD Biosciences CCR7 antibody (BD Pharmingen, 150503) was used in flow cytometry on human samples . J Virol (2014) ncbi
mouse monoclonal (150503)
  • flow cytometry; human
BD Biosciences CCR7 antibody (BD Bioscience, clone 150503) was used in flow cytometry on human samples . Mol Ther (2014) ncbi
mouse monoclonal (150503)
  • flow cytometry; human; loading ...; fig 3a
In order to assess the effect of delayed administration of the BCG vaccine on the induced immune response in Ugandan children, BD Biosciences CCR7 antibody (BD Biosciences, 150 503) was used in flow cytometry on human samples (fig 3a). J Infect Dis (2014) ncbi
rat monoclonal (3D12)
  • flow cytometry; human
BD Biosciences CCR7 antibody (BD Pharmingen, 552176) was used in flow cytometry on human samples . PLoS ONE (2013) ncbi
Articles Reviewed
  1. Bennstein S, Weinhold S, Manser A, Scherenschlich N, Noll A, Raba K, et al. Umbilical cord blood-derived ILC1-like cells constitute a novel precursor for mature KIR+NKG2A- NK cells. elife. 2020;9: pubmed publisher
  2. Ma T, Luo X, George A, Mukherjee G, Sen N, Spitzer T, et al. HIV efficiently infects T cells from the endometrium and remodels them to promote systemic viral spread. elife. 2020;9: pubmed publisher
  3. Wei J, Mattapallil M, Horai R, Jittayasothorn Y, Modi A, Sen H, et al. A novel role for lipoxin A4 in driving a lymph node-eye axis that controls autoimmunity to the neuroretina. elife. 2020;9: pubmed publisher
  4. Park J, Botting R, Domínguez Conde C, Popescu D, Lavaert M, Kunz D, et al. A cell atlas of human thymic development defines T cell repertoire formation. Science. 2020;367: pubmed publisher
  5. Mosaheb M, Dobrikova E, Brown M, Yang Y, Cable J, Okada H, et al. Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity. Nat Commun. 2020;11:524 pubmed publisher
  6. Kim A, Han C, Driver I, Olow A, Sewell A, Zhang Z, et al. LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody-Induced Tumor Cell Killing by Effector CD8+ T Cells. J Immunol. 2019;203:1076-1087 pubmed publisher
  7. Lau E, Carroll E, Callender L, Hood G, Berryman V, Pattrick M, et al. Type 2 diabetes is associated with the accumulation of senescent T cells. Clin Exp Immunol. 2019;197:205-213 pubmed publisher
  8. Burel J, Pomaznoy M, Lindestam Arlehamn C, Weiskopf D, da Silva Antunes R, Jung Y, et al. Circulating T cell-monocyte complexes are markers of immune perturbations. elife. 2019;8: pubmed publisher
  9. Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;: pubmed publisher
  10. Lim S, Kim J, Jeon S, Shin M, Kwon J, Kim T, et al. Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients. Front Immunol. 2019;10:496 pubmed publisher
  11. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  12. Remmerswaal E, Hombrink P, Nota B, Pircher H, ten Berge I, van Lier R, et al. Expression of IL-7Rα and KLRG1 defines functionally distinct CD8+ T-cell populations in humans. Eur J Immunol. 2019;49:694-708 pubmed publisher
  13. Finney O, Brakke H, Rawlings Rhea S, Hicks R, Doolittle D, López M, et al. CD19 CAR T cell product and disease attributes predict leukemia remission durability. J Clin Invest. 2019;129:2123-2132 pubmed publisher
  14. Karimzadeh H, Kiraithe M, Oberhardt V, Salimi Alizei E, Bockmann J, Schulze zur Wiesch J, et al. Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8+ T Cells and Evolve at the Population Level. Gastroenterology. 2019;156:1820-1833 pubmed publisher
  15. Mayassi T, Ladell K, Gudjonson H, McLaren J, Shaw D, Tran M, et al. Chronic Inflammation Permanently Reshapes Tissue-Resident Immunity in Celiac Disease. Cell. 2019;176:967-981.e19 pubmed publisher
  16. Faliti C, Gualtierotti R, Rottoli E, Gerosa M, Perruzza L, Romagnani A, et al. P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus. J Exp Med. 2019;216:317-336 pubmed publisher
  17. Jiao X, Shu G, Liu H, Zhang Q, Ma Z, Ren C, et al. The Diagnostic Value of Chemokine/Chemokine Receptor Pairs in Hepatocellular Carcinoma and Colorectal Liver Metastasis. J Histochem Cytochem. 2019;67:299-308 pubmed publisher
  18. Collins P, Cella M, Porter S, Li S, Gurewitz G, Hong H, et al. Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells. Cell. 2019;176:348-360.e12 pubmed publisher
  19. Ha D, Tanaka A, Kibayashi T, Tanemura A, Sugiyama D, Wing J, et al. Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody. Proc Natl Acad Sci U S A. 2019;116:609-618 pubmed publisher
  20. Amelio P, Portevin D, Hella J, Reither K, Kamwela L, Lweno O, et al. HIV Infection Functionally Impairs Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses. J Virol. 2019;93: pubmed publisher
  21. Wang M, Tang C, Xing R, Liu X, Han X, Liu Y, et al. WDR81 regulates adult hippocampal neurogenesis through endosomal SARA-TGFβ signaling. Mol Psychiatry. 2018;: pubmed publisher
  22. Kim C, Hu B, Jadhav R, Jin J, Zhang H, Cavanagh M, et al. Activation of miR-21-Regulated Pathways in Immune Aging Selects against Signatures Characteristic of Memory T Cells. Cell Rep. 2018;25:2148-2162.e5 pubmed publisher
  23. Dias J, Boulouis C, Gorin J, van den Biggelaar R, Lal K, Gibbs A, et al. The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool. Proc Natl Acad Sci U S A. 2018;115:E11513-E11522 pubmed publisher
  24. Hoang T, Harper J, Pino M, Wang H, Micci L, King C, et al. Bone Marrow-Derived CD4+ T Cells Are Depleted in Simian Immunodeficiency Virus-Infected Macaques and Contribute to the Size of the Replication-Competent Reservoir. J Virol. 2019;93: pubmed publisher
  25. Kong X, Martinez Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick E, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973-985 pubmed publisher
  26. D Addio F, Vergani A, Potena L, Maestroni A, Usuelli V, Ben Nasr M, et al. P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes. J Clin Invest. 2018;128:3490-3503 pubmed publisher
  27. Jung I, Kim Y, Yu H, Lee M, Kim S, Lee J. CRISPR/Cas9-Mediated Knockout of DGK Improves Antitumor Activities of Human T Cells. Cancer Res. 2018;78:4692-4703 pubmed publisher
  28. Moysi E, Pallikkuth S, de Armas L, Gonzalez L, Ambrozak D, George V, et al. Altered immune cell follicular dynamics in HIV infection following influenza vaccination. J Clin Invest. 2018;128:3171-3185 pubmed publisher
  29. Armas González E, Domínguez Luis M, Díaz Martín A, Arce Franco M, Castro Hernandez J, Danelon G, et al. Role of CXCL13 and CCL20 in the recruitment of B cells to inflammatory foci in chronic arthritis. Arthritis Res Ther. 2018;20:114 pubmed publisher
  30. Wang B, Zuo J, Kang W, Wei Q, Li J, Wang C, et al. Generation of Hutat2:Fc Knockin Primary Human Monocytes Using CRISPR/Cas9. Mol Ther Nucleic Acids. 2018;11:130-141 pubmed publisher
  31. Georgiev H, Ravens I, Papadogianni G, Halle S, Malissen B, Loots G, et al. Shared and Unique Features Distinguishing Follicular T Helper and Regulatory Cells of Peripheral Lymph Node and Peyer's Patches. Front Immunol. 2018;9:714 pubmed publisher
  32. Basu A, Munir S, Mulaw M, Singh K, Crisan D, Sindrilaru A, et al. A Novel S100A8/A9 Induced Fingerprint of Mesenchymal Stem Cells associated with Enhanced Wound Healing. Sci Rep. 2018;8:6205 pubmed publisher
  33. Hailemichael Y, Woods A, Fu T, He Q, Nielsen M, Hasan F, et al. Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy. J Clin Invest. 2018;128:1338-1354 pubmed publisher
  34. Seki A, Rutz S. Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells. J Exp Med. 2018;215:985-997 pubmed publisher
  35. Gee M, Han A, Lofgren S, Beausang J, Mendoza J, Birnbaum M, et al. Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell. 2018;172:549-563.e16 pubmed publisher
  36. Amodio D, Cotugno N, Macchiarulo G, Rocca S, Dimopoulos Y, Castrucci M, et al. Quantitative Multiplexed Imaging Analysis Reveals a Strong Association between Immunogen-Specific B Cell Responses and Tonsillar Germinal Center Immune Dynamics in Children after Influenza Vaccination. J Immunol. 2018;200:538-550 pubmed publisher
  37. Hutten T, Norde W, Woestenenk R, Wang R, Maas F, Kester M, et al. Increased Coexpression of PD-1, TIGIT, and KLRG-1 on Tumor-Reactive CD8+ T Cells During Relapse after Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2018;24:666-677 pubmed publisher
  38. Moreno Cubero E, Subira D, Sanz de Villalobos E, Parra Cid T, Madejon A, Miquel J, et al. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1low HCV-Specific CD8+ Cell Reactivity. J Virol. 2018;92: pubmed publisher
  39. Capece T, Walling B, Lim K, Kim K, Bae S, Chung H, et al. A novel intracellular pool of LFA-1 is critical for asymmetric CD8+ T cell activation and differentiation. J Cell Biol. 2017;216:3817-3829 pubmed publisher
  40. Matos T, O Malley J, Lowry E, Hamm D, Kirsch I, Robins H, et al. Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing ?? T cell clones. J Clin Invest. 2017;127:4031-4041 pubmed publisher
  41. Molnar C, Scherer A, Baraliakos X, de Hooge M, Micheroli R, Exer P, et al. TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis. 2018;77:63-69 pubmed publisher
  42. Hensel M, Peng T, Cheng A, De Rosa S, Wald A, Laing K, et al. Selective Expression of CCR10 and CXCR3 by Circulating Human Herpes Simplex Virus-Specific CD8 T Cells. J Virol. 2017;91: pubmed publisher
  43. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  44. Meniailo M, Malashchenko V, Shmarov V, Gazatova N, Melashchenko O, Goncharov A, et al. Direct effects of interleukin-8 on growth and functional activity of T lymphocytes. Int Immunopharmacol. 2017;50:178-185 pubmed publisher
  45. de Wolf A, van Aalst S, Ludwig I, Bodinham C, Lewis D, van der Zee R, et al. Regulatory T cell frequencies and phenotypes following anti-viral vaccination. PLoS ONE. 2017;12:e0179942 pubmed publisher
  46. Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed publisher
  47. Buskermolen J, Roffel S, Gibbs S. Stimulation of oral fibroblast chemokine receptors identifies CCR3 and CCR4 as potential wound healing targets. J Cell Physiol. 2017;232:2996-3005 pubmed publisher
  48. Nishimura Y, Gautam R, Chun T, Sadjadpour R, Foulds K, Shingai M, et al. Early antibody therapy can induce long-lasting immunity to SHIV. Nature. 2017;543:559-563 pubmed publisher
  49. van der Geest K, Wang Q, Eijsvogels T, Koenen H, Joosten I, Brouwer E, et al. Changes in peripheral immune cell numbers and functions in octogenarian walkers - an acute exercise study. Immun Ageing. 2017;14:5 pubmed publisher
  50. Szabo P, Goswami A, Mazzuca D, Kim K, O Gorman D, Hess D, et al. Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology. J Immunol. 2017;198:2805-2818 pubmed publisher
  51. Smith N, Pietrancosta N, Davidson S, Dutrieux J, Chauveau L, Cutolo P, et al. Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement. Nat Commun. 2017;8:14253 pubmed publisher
  52. Watanabe N, Bajgain P, Sukumaran S, Ansari S, Heslop H, Rooney C, et al. Fine-tuning the CAR spacer improves T-cell potency. Oncoimmunology. 2016;5:e1253656 pubmed publisher
  53. Jeffery H, Jeffery L, Lutz P, Corrigan M, Webb G, Hirschfield G, et al. Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases. Clin Exp Immunol. 2017;188:394-411 pubmed publisher
  54. Raposo R, de Mulder Rougvie M, Paquin Proulx D, Brailey P, Cabido V, Zdinak P, et al. IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis. JCI Insight. 2017;2:e85811 pubmed publisher
  55. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed publisher
  56. Roberts E, Carnathan D, Li H, Shaw G, Silvestri G, Betts M. Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques. PLoS Pathog. 2016;12:e1006135 pubmed publisher
  57. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  58. Fujiwara Y, Hizukuri Y, Yamashiro K, Makita N, Ohnishi K, Takeya M, et al. Guanylate-binding protein 5 is a marker of interferon-γ-induced classically activated macrophages. Clin Transl Immunology. 2016;5:e111 pubmed
  59. Comunanza V, Cora D, Orso F, Consonni F, Middonti E, Di Nicolantonio F, et al. VEGF blockade enhances the antitumor effect of BRAFV600E inhibition. EMBO Mol Med. 2017;9:219-237 pubmed publisher
  60. Sairafi D, Stikvoort A, Gertow J, Mattsson J, Uhlin M. Donor Cell Composition and Reactivity Predict Risk of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. J Immunol Res. 2016;2016:5601204 pubmed
  61. Lévy R, Okada S, Béziat V, Moriya K, Liu C, Chai L, et al. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proc Natl Acad Sci U S A. 2016;113:E8277-E8285 pubmed publisher
  62. Nish S, Zens K, Kratchmarov R, Lin W, Adams W, Chen Y, et al. CD4+ T cell effector commitment coupled to self-renewal by asymmetric cell divisions. J Exp Med. 2017;214:39-47 pubmed publisher
  63. Ryan P, Sumaria N, Holland C, Bradford C, Izotova N, Grandjean C, et al. Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals. Proc Natl Acad Sci U S A. 2016;113:14378-14383 pubmed
  64. Tomic A, Varanasi P, Golemac M, Malic S, Riese P, Borst E, et al. Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand. PLoS Pathog. 2016;12:e1006015 pubmed publisher
  65. Yokota Nakatsuma A, Ohoka Y, Takeuchi H, Song S, Iwata M. Beta 1-integrin ligation and TLR ligation enhance GM-CSF-induced ALDH1A2 expression in dendritic cells, but differentially regulate their anti-inflammatory properties. Sci Rep. 2016;6:37914 pubmed publisher
  66. Cecchinato V, Bernasconi E, Speck R, Proietti M, Sauermann U, D Agostino G, et al. Impairment of CCR6+ and CXCR3+ Th Cell Migration in HIV-1 Infection Is Rescued by Modulating Actin Polymerization. J Immunol. 2017;198:184-195 pubmed
  67. Srivastava R, Khan A, Garg S, Syed S, Furness J, Vahed H, et al. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocula. J Virol. 2017;91: pubmed publisher
  68. Serr I, Fürst R, Ott V, Scherm M, Nikolaev A, Gökmen F, et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6659-E6668 pubmed
  69. Sen D, Kaminski J, Barnitz R, Kurachi M, Gerdemann U, Yates K, et al. The epigenetic landscape of T cell exhaustion. Science. 2016;354:1165-1169 pubmed
  70. Dyer W, Tan J, Day T, Kiers L, Kiernan M, Yiannikas C, et al. Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. Brain Behav. 2016;6:e00516 pubmed
  71. Georgiev H, Ravens I, Benarafa C, Forster R, Bernhardt G. Distinct gene expression patterns correlate with developmental and functional traits of iNKT subsets. Nat Commun. 2016;7:13116 pubmed publisher
  72. Miles B, Miller S, Folkvord J, Levy D, Rakasz E, Skinner P, et al. Follicular Regulatory CD8 T Cells Impair the Germinal Center Response in SIV and Ex Vivo HIV Infection. PLoS Pathog. 2016;12:e1005924 pubmed publisher
  73. Komdeur F, Wouters M, Workel H, Tijans A, Terwindt A, Brunekreeft K, et al. CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy. Oncotarget. 2016;7:75130-75144 pubmed publisher
  74. Boddupalli C, Nair S, Gray S, Nowyhed H, Verma R, Gibson J, et al. ABC transporters and NR4A1 identify a quiescent subset of tissue-resident memory T cells. J Clin Invest. 2016;126:3905-3916 pubmed publisher
  75. Ayala V, Trivett M, Barsov E, Jain S, Piatak M, Trubey C, et al. Adoptive Transfer of Engineered Rhesus Simian Immunodeficiency Virus-Specific CD8+ T Cells Reduces the Number of Transmitted/Founder Viruses Established in Rhesus Macaques. J Virol. 2016;90:9942-9952 pubmed publisher
  76. Kagoya Y, Nakatsugawa M, Yamashita Y, Ochi T, Guo T, Anczurowski M, et al. BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models. J Clin Invest. 2016;126:3479-94 pubmed publisher
  77. Matkar P, Singh K, Rudenko D, Kim Y, Kuliszewski M, Prud homme G, et al. Novel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinoma. Oncotarget. 2016;7:69489-69506 pubmed publisher
  78. Leong Y, Chen Y, Ong H, Wu D, Man K, Deléage C, et al. CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles. Nat Immunol. 2016;17:1187-96 pubmed publisher
  79. Demers K, Makedonas G, Buggert M, Eller M, Ratcliffe S, Goonetilleke N, et al. Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection. PLoS Pathog. 2016;12:e1005805 pubmed publisher
  80. Chen H, Händel N, Ngeow J, Muller J, Huhn M, Yang H, et al. Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells. J Allergy Clin Immunol. 2017;139:607-620.e15 pubmed publisher
  81. Franzese O, Palermo B, Di Donna C, Sperduti I, Ferraresi V, Stabile H, et al. Polyfunctional Melan-A-specific tumor-reactive CD8(+) T cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOS. Oncoimmunology. 2016;5:e1114203 pubmed publisher
  82. Fromentin R, Bakeman W, Lawani M, Khoury G, Hartogensis W, DaFonseca S, et al. CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART. PLoS Pathog. 2016;12:e1005761 pubmed publisher
  83. Stadinski B, Shekhar K, Gomez Tourino I, Jung J, Sasaki K, Sewell A, et al. Hydrophobic CDR3 residues promote the development of self-reactive T cells. Nat Immunol. 2016;17:946-55 pubmed publisher
  84. Saha A, O Connor R, Thangavelu G, Lovitch S, Dandamudi D, Wilson C, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest. 2016;126:2642-60 pubmed publisher
  85. Ramos C, Savoldo B, Torrano V, Ballard B, Zhang H, Dakhova O, et al. Clinical responses with T lymphocytes targeting malignancy-associated ? light chains. J Clin Invest. 2016;126:2588-96 pubmed publisher
  86. Ma Q, Garber H, Lu S, He H, Tallis E, Ding X, et al. A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells. Cytotherapy. 2016;18:985-94 pubmed publisher
  87. van der Heiden M, van Zelm M, Bartol S, de Rond L, Berbers G, Boots A, et al. Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females. Sci Rep. 2016;6:26892 pubmed publisher
  88. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed publisher
  89. Neumann B, Shi T, Gan L, Klippert A, Daskalaki M, Stolte Leeb N, et al. Comprehensive panel of cross-reacting monoclonal antibodies for analysis of different immune cells and their distribution in the common marmoset (Callithrix jacchus). J Med Primatol. 2016;45:139-46 pubmed publisher
  90. Hellmann J, Sansbury B, Holden C, Tang Y, Wong B, Wysoczynski M, et al. CCR7 Maintains Nonresolving Lymph Node and Adipose Inflammation in Obesity. Diabetes. 2016;65:2268-81 pubmed publisher
  91. Li W, Liu L, Gomez A, Zhang J, Ramadan A, Zhang Q, et al. Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease. JCI Insight. 2016;1: pubmed publisher
  92. Liu B, Shi Y, Peng W, Zhang Q, Liu J, Chen N, et al. Diosmetin induces apoptosis by upregulating p53 via the TGF-? signal pathway in HepG2 hepatoma cells. Mol Med Rep. 2016;14:159-64 pubmed publisher
  93. Stikvoort A, Sundin M, Uzunel M, Gertow J, Sundberg B, Schaffer M, et al. Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?. PLoS ONE. 2016;11:e0154737 pubmed publisher
  94. Harper I, Ali J, Harper S, Wlodek E, Alsughayyir J, Negus M, et al. Augmentation of Recipient Adaptive Alloimmunity by Donor Passenger Lymphocytes within the Transplant. Cell Rep. 2016;15:1214-27 pubmed publisher
  95. Qualai J, Li L, Cantero J, Tarrats A, Fernández M, Sumoy L, et al. Expression of CD11c Is Associated with Unconventional Activated T Cell Subsets with High Migratory Potential. PLoS ONE. 2016;11:e0154253 pubmed publisher
  96. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed publisher
  97. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  98. Jost T, Borga C, Radaelli E, Romagnani A, Perruzza L, Omodho L, et al. Role of CXCR4-mediated bone marrow colonization in CNS infiltration by T cell acute lymphoblastic leukemia. J Leukoc Biol. 2016;99:1077-87 pubmed publisher
  99. Xiong Y, Ahmad S, Iwami D, Brinkman C, Bromberg J. T-bet Regulates Natural Regulatory T Cell Afferent Lymphatic Migration and Suppressive Function. J Immunol. 2016;196:2526-40 pubmed publisher
  100. Setoguchi R. IL-15 boosts the function and migration of human terminally differentiated CD8+ T cells by inducing a unique gene signature. Int Immunol. 2016;28:293-305 pubmed publisher
  101. Gupta S, Termini J, Issac B, Guirado E, Stone G. Constitutively Active MAVS Inhibits HIV-1 Replication via Type I Interferon Secretion and Induction of HIV-1 Restriction Factors. PLoS ONE. 2016;11:e0148929 pubmed publisher
  102. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  103. James E, Gates T, LaFond R, Yamamoto S, Ni C, Mai D, et al. Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome. PLoS Pathog. 2016;12:e1005375 pubmed publisher
  104. Li L, Jiang Y, Lao S, Yang B, Yu S, Zhang Y, et al. Mycobacterium tuberculosis-Specific IL-21+IFN-γ+CD4+ T Cells Are Regulated by IL-12. PLoS ONE. 2016;11:e0147356 pubmed publisher
  105. Vargas Inchaustegui D, Demers A, Shaw J, Kang G, Ball D, Tuero I, et al. Vaccine Induction of Lymph Node-Resident Simian Immunodeficiency Virus Env-Specific T Follicular Helper Cells in Rhesus Macaques. J Immunol. 2016;196:1700-10 pubmed publisher
  106. Paris R, Petrovas C, Ferrando Martinez S, Moysi E, Boswell K, Archer E, et al. Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression. PLoS ONE. 2015;10:e0144767 pubmed publisher
  107. Kiermaier E, Moussion C, Veldkamp C, Gerardy Schahn R, de Vries I, Williams L, et al. Polysialylation controls dendritic cell trafficking by regulating chemokine recognition. Science. 2016;351:186-90 pubmed publisher
  108. Javed A, Leuchte N, Neumann B, Sopper S, Sauermann U. Noncytolytic CD8+ Cell Mediated Antiviral Response Represents a Strong Element in the Immune Response of Simian Immunodeficiency Virus-Infected Long-Term Non-Progressing Rhesus Macaques. PLoS ONE. 2015;10:e0142086 pubmed publisher
  109. Li R, Rezk A, Miyazaki Y, Hilgenberg E, Touil H, Shen P, et al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci Transl Med. 2015;7:310ra166 pubmed publisher
  110. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed publisher
  111. Mitson Salazar A, Yin Y, Wansley D, Young M, Bolan H, Arceo S, et al. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function. J Allergy Clin Immunol. 2016;137:907-18.e9 pubmed publisher
  112. Schnorfeil F, Lichtenegger F, Emmerig K, Schlueter M, Neitz J, Draenert R, et al. T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment. J Hematol Oncol. 2015;8:93 pubmed publisher
  113. Melgaço J, Morgado L, Santiago M, Oliveira J, Lewis Ximenez L, Hasselmann B, et al. A single dose of inactivated hepatitis A vaccine promotes HAV-specific memory cellular response similar to that induced by a natural infection. Vaccine. 2015;33:3813-20 pubmed publisher
  114. Zhao L, Liu S, Che X, Hou K, Ma Y, Li C, et al. Bufalin inhibits TGF-β-induced epithelial-to-mesenchymal transition and migration in human lung cancer A549 cells by downregulating TGF-β receptors. Int J Mol Med. 2015;36:645-52 pubmed publisher
  115. Mikucki M, Fisher D, Matsuzaki J, Skitzki J, Gaulin N, Muhitch J, et al. Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints. Nat Commun. 2015;6:7458 pubmed publisher
  116. Chen Y, Zhu H, Zhang N, Shen L, Wang R, Zhou J, et al. Temporal kinetics of macrophage polarization in the injured rat spinal cord. J Neurosci Res. 2015;93:1526-33 pubmed publisher
  117. Stenger E, Chiang K, Haight A, Qayed M, Kean L, Horan J. Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases. Biol Blood Marrow Transplant. 2015;21:1845-52 pubmed publisher
  118. Chowdhury A, Hayes T, Bosinger S, Lawson B, Vanderford T, Schmitz J, et al. Differential Impact of In Vivo CD8+ T Lymphocyte Depletion in Controller versus Progressor Simian Immunodeficiency Virus-Infected Macaques. J Virol. 2015;89:8677-86 pubmed publisher
  119. DaFonseca S, Niessl J, Pouvreau S, Wacleche V, Gosselin A, Cleret Buhot A, et al. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART. Retrovirology. 2015;12:38 pubmed publisher
  120. Lenz N, Schindler T, Kagina B, Zhang J, Lukindo T, Mpina M, et al. Antiviral Innate Immune Activation in HIV-Infected Adults Negatively Affects H1/IC31-Induced Vaccine-Specific Memory CD4+ T Cells. Clin Vaccine Immunol. 2015;22:688-96 pubmed publisher
  121. Trabanelli S, Lecciso M, Salvestrini V, Cavo M, Očadlíková D, Lemoli R, et al. PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune response. J Immunol Res. 2015;2015:253191 pubmed publisher
  122. Yukl S, Shergill A, Girling V, Li Q, Killian M, Epling L, et al. Site-specific differences in T cell frequencies and phenotypes in the blood and gut of HIV-uninfected and ART-treated HIV+ adults. PLoS ONE. 2015;10:e0121290 pubmed publisher
  123. Tian X, Zhang A, Qiu C, Wang W, Yang Y, Qiu C, et al. The upregulation of LAG-3 on T cells defines a subpopulation with functional exhaustion and correlates with disease progression in HIV-infected subjects. J Immunol. 2015;194:3873-82 pubmed publisher
  124. Steindor M, Nkwouano V, Mayatepek E, Mackenzie C, Schramm D, Jacobsen M. Rapid detection and immune characterization of Mycobacterium abscessus infection in cystic fibrosis patients. PLoS ONE. 2015;10:e0119737 pubmed publisher
  125. Claiborne D, Prince J, Scully E, Macharia G, Micci L, Lawson B, et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proc Natl Acad Sci U S A. 2015;112:E1480-9 pubmed publisher
  126. Severson J, Serracino H, Mateescu V, Raeburn C, McIntyre R, Sams S, et al. PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer. Cancer Immunol Res. 2015;3:620-30 pubmed publisher
  127. Rizzo A, Vasco C, Girgenti V, Fugnanesi V, Calatozzolo C, Canazza A, et al. Melanoma cells homing to the brain: an in vitro model. Biomed Res Int. 2015;2015:476069 pubmed publisher
  128. Bhargava P, Gocke A, Calabresi P. 1,25-Dihydroxyvitamin D3 impairs the differentiation of effector memory T cells in vitro in multiple sclerosis patients and healthy controls. J Neuroimmunol. 2015;279:20-4 pubmed publisher
  129. Boyle M, Jagannathan P, Bowen K, McIntyre T, Vance H, Farrington L, et al. Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations. J Infect Dis. 2015;212:416-25 pubmed publisher
  130. Srivastava R, Khan A, Spencer D, Vahed H, Lopes P, Thai N, et al. HLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgenic. J Immunol. 2015;194:2232-48 pubmed publisher
  131. Abdel Mohsen M, Wang C, Strain M, Lada S, Deng X, Cockerham L, et al. Select host restriction factors are associated with HIV persistence during antiretroviral therapy. AIDS. 2015;29:411-20 pubmed publisher
  132. Gerner W, Talker S, Koinig H, Sedlak C, Mair K, Saalmüller A. Phenotypic and functional differentiation of porcine αβ T cells: current knowledge and available tools. Mol Immunol. 2015;66:3-13 pubmed publisher
  133. Van Eyck L, Hershfield M, Pombal D, Kelly S, Ganson N, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135:283-7.e5 pubmed publisher
  134. Willmann K, Klaver S, DoÄŸu F, Santos Valente E, Garncarz W, Bilic I, et al. Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity. Nat Commun. 2014;5:5360 pubmed publisher
  135. van der Waart A, van de Weem N, Maas F, Kramer C, Kester M, Falkenburg J, et al. Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy. Blood. 2014;124:3490-500 pubmed publisher
  136. Luetke Eversloh M, Hammer Q, Durek P, Nordström K, Gasparoni G, Pink M, et al. Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog. 2014;10:e1004441 pubmed publisher
  137. Weiskopf D, Angelo M, Bangs D, Sidney J, Paul S, Peters B, et al. The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes. J Virol. 2015;89:120-8 pubmed publisher
  138. Gerna G, Lilleri D, Fornara C, Bruno F, Gabanti E, Cane I, et al. Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host. J Gen Virol. 2015;96:360-9 pubmed publisher
  139. Alnabhan R, Madrigal A, Saudemont A. Differential activation of cord blood and peripheral blood natural killer cells by cytokines. Cytotherapy. 2015;17:73-85 pubmed publisher
  140. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed publisher
  141. Arlehamn C, Seumois G, Gerasimova A, Huang C, Fu Z, Yue X, et al. Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features. J Immunol. 2014;193:2931-40 pubmed publisher
  142. Kivisakk P, Francois K, Mbianda J, Gandhi R, Weiner H, Khoury S. Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis. PLoS ONE. 2014;9:e103716 pubmed publisher
  143. Said A, Bock S, Müller G, Weindl G. Inflammatory conditions distinctively alter immunological functions of Langerhans-like cells and dendritic cells in vitro. Immunology. 2015;144:218-30 pubmed publisher
  144. Buggert M, Tauriainen J, Yamamoto T, Frederiksen J, Ivarsson M, Michaelsson J, et al. T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection. PLoS Pathog. 2014;10:e1004251 pubmed publisher
  145. Pegram H, Purdon T, van Leeuwen D, Curran K, Giralt S, Barker J, et al. IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia. Leukemia. 2015;29:415-22 pubmed publisher
  146. Jacquelin B, Petitjean G, Kunkel D, Liovat A, Jochems S, Rogers K, et al. Innate immune responses and rapid control of inflammation in African green monkeys treated or not with interferon-alpha during primary SIVagm infection. PLoS Pathog. 2014;10:e1004241 pubmed publisher
  147. Kim K, Chung B, Kim B, Cho M, Yang C. The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients. Immunology. 2015;144:68-78 pubmed publisher
  148. Payne T, Blackinton J, Frisbee A, Pickeral J, Sawant S, Vandergrift N, et al. Transcriptional and posttranscriptional regulation of cytokine gene expression in HIV-1 antigen-specific CD8+ T cells that mediate virus inhibition. J Virol. 2014;88:9514-28 pubmed publisher
  149. Ito S, Bollard C, Carlsten M, Melenhorst J, Biancotto A, Wang E, et al. Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers. Mol Ther. 2014;22:1388-1395 pubmed publisher
  150. Søndergaard J, Vinner L, Brix S. Natural mannosylation of HIV-1 gp120 imposes no immunoregulatory effects in primary human plasmacytoid dendritic cells. Mol Immunol. 2014;59:180-7 pubmed publisher
  151. Sereti I, Estes J, Thompson W, Morcock D, Fischl M, Croughs T, et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014;10:e1003890 pubmed publisher
  152. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed publisher
  153. Park S, Veerapu N, Shin E, Biancotto A, McCoy J, Capone S, et al. Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection. Nat Med. 2013;19:1638-42 pubmed publisher
  154. Lutwama F, Kagina B, Wajja A, Waiswa F, Mansoor N, Kirimunda S, et al. Distinct T-cell responses when BCG vaccination is delayed from birth to 6 weeks of age in Ugandan infants. J Infect Dis. 2014;209:887-97 pubmed publisher
  155. Wijewardana V, Kristoff J, Xu C, Ma D, Haret Richter G, Stock J, et al. Kinetics of myeloid dendritic cell trafficking and activation: impact on progressive, nonprogressive and controlled SIV infections. PLoS Pathog. 2013;9:e1003600 pubmed publisher
  156. Svajger U, Obermajer N, Jeras M. IFN-?-rich environment programs dendritic cells toward silencing of cytotoxic immune responses. J Leukoc Biol. 2014;95:33-46 pubmed publisher
  157. Guo J, Lou W, Ji Y, Zhang S. Effect of CCR7, CXCR4 and VEGF-C on the lymph node metastasis of human pancreatic ductal adenocarcinoma. Oncol Lett. 2013;5:1572-1578 pubmed
  158. de Poorter C, Baertsoen K, Lannoy V, Parmentier M, Springael J. Consequences of ChemR23 heteromerization with the chemokine receptors CXCR4 and CCR7. PLoS ONE. 2013;8:e58075 pubmed publisher
  159. Tour G, Wendel M, Tcacencu I. Bone marrow stromal cells enhance the osteogenic properties of hydroxyapatite scaffolds by modulating the foreign body reaction. J Tissue Eng Regen Med. 2014;8:841-9 pubmed publisher
  160. Correia M, Costa A, Uhrberg M, Cardoso E, Arosa F. IL-15 induces CD8+ T cells to acquire functional NK receptors capable of modulating cytotoxicity and cytokine secretion. Immunobiology. 2011;216:604-12 pubmed publisher